Continuous Noninvasive Blood Pressure Monitoring of Beat-by-Beat Blood Pressure and Heart Rate Using Caretaker® Compared to Invasive Arterial Catheter In the Intensive Care Unit

2021 ◽  
Author(s):  
Younghoon Kwon ◽  
Patrick L. Stafford ◽  
Kyle Enfield ◽  
Sula Mazimba ◽  
Martin C. Baruch
Keyword(s):  
Blood Pressure ◽  
Intensive Care Unit ◽  
Heart Rate ◽  
Intensive Care ◽  
Blood Pressure Monitoring ◽  
Arterial Catheter ◽  
Pressure Monitoring ◽  
Noninvasive Blood Pressure

scholarly journals The Accuracy of Blood Pressure Monitoring Using the Senbiosys Ring: A Study on Patients Undergoing Coronary Angiography and Patients in the Intensive Care Unit

2021 ◽  
Author(s):  
Serj Haddad ◽  
Sara Schukraft ◽  
Assim Boukhayma ◽  
Anthony Barison ◽  
Yannick Faucherre ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Intensive Care Unit ◽  
Intensive Care ◽  
Standard Deviation ◽  
Coronary Angiography ◽  
Blood Pressure Monitoring ◽  
Mean Difference ◽  
Arterial Line ◽  
Pressure Monitoring ◽  
The Mean

Abstract The study NCT04379986 aims at evaluating the performance of the Senbiosys technology in monitoring blood pressure (BP) values for elderly patients: 25 patients undergoing coronary angiography, aged 68.92 ± 6.41 years, and 10 patients in the intensive care unit (ICU), aged 71.90 ± 8.56 years. The technology is based on pulse wave analysis (PWA) of low-power photoplethysmography (PPG) from the SBF2003 ring. The PPG recordings are processed by the PPG-based blood pressure monitoring (PPG-BPM) algorithm 1 to generate systolic BP (SBP) and diastolic BP (DBP) estimates. For the SBP, the mean difference ± standard deviation between the reference arterial line and the PPG-BPM values is 0 ± 5.06 mmHg for the patients undergoing coronary angiography and 0 ± 7.46 mmHg for the patients in the ICU. For the DBP, the mean difference ± standard deviation between the reference arterial line and the PPG-BPM values is 0 ± 1.85 mmHg for the patients undergoing coronary angiography and 0 ± 4.17 mmHg for the patients in the ICU. The results show that the accuracy of our algorithm is within the 5 ± 8 mmHg ISO/ANSI/AAMI protocol requirement.

Noninvasive Blood Pressure Monitoring Evaluation of Verapamil Slow-Release 240-mg Antihypertensive Effectiveness

1989 ◽  
Vol 13 ◽  
pp. S38-S41 ◽  
Author(s):  
Salvatore Novo ◽  
Gaetano Alaimo ◽  
Maurizio Giuseppe Abrignani ◽  
Barbara Longo ◽  
Giuseppe Muratore ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Slow Release ◽  
Blood Pressure Monitoring ◽  
Pressure Monitoring ◽  
Noninvasive Blood Pressure

Ambulatory Blood Pressure Recordings in Children and Adolescents

PEDIATRICS ◽  
1994 ◽  
Vol 94 (2) ◽  
pp. 180-184
Author(s):  
Gregory A. Harshfield ◽  
Bruce S. Alpert ◽  
Derrick A. Pulliam ◽  
Grant W. Somes ◽  
Dawn K. Wilson
Keyword(s):  
Blood Pressure ◽  
Heart Rate ◽  
Systolic Blood Pressure ◽  
Ambulatory Blood Pressure ◽  
Reference Data ◽  
Blood Pressure Monitoring ◽  
Age Groups ◽  
Specific Reference ◽  
Pressure Monitoring ◽  
Black And White

Objective. To provide reference data for ambulatory blood pressure monitoring (ABPM) and to determine the influence of age, sex, and race on these values. Methods. ABPM was performed on 300 healthy, normotensive boys and girls between the ages of 10 and 18 years, including 160 boys and 140 girls, of whom 149 were white and 151 were black. Mean systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) while awake and during sleep were calculated for black and white boys and girls aged 10 to 12 years, 13 to 15 years, and 16 to 18 years. Results. Boys compared with girls 10 to 12 years of age had higher mean (±SD) SBP (115 ± 9 vs 112 ± 9 mm Hg; P < .01) and DBP (67 ± 7 vs 65 ± 5 mm Hg; P < .01) while awake. Boys compared to girls 13 to 15 years of age had higher SBP while awake (116 ± 11 vs 112 ± 8 mm Hg; P < .01). Boys compared with girls 16 to 18 years of age had higher SBP while awake (125 ± 12 vs 111 ± 9 mm Hg; P < .01) and during sleep (116 ± 11 vs 106 ± 9 mm Hg). Comparisons within sex showed similar changes with age for boys and girls. Blacks compared with whites 13 to 15 years of age had higher SBP during sleep (109 ± 11 vs 105 ± 10 mm Hg; P < .01), and blacks compared with whites 16 to 18 years of age had higher DBP during sleep (66 ± 7 vs 58 ± 6 mm Hg; P < .01). Comparisons across age groups within race showed that blacks 16 to 18 years of age had higher SBP during sleep than blacks 10 to 12 years of age (109 ± 11 vs 104 ± 10 mm Hg), and higher DBP during sleep (66 ± 7 mm Hg; P < .01) than blacks 10 to 12 years of age (61 ± 7 mm Hg; P < .01) and 13 to 15 years of age (61 ± 8; P < .01 mm Hg). The changes with age were not significant for white subjects. Conclusion. These results provide age-specific reference data for ABPM in youths. These values differ by sex (boys more than girls) and race (Blacks more than Whites).

scholarly journals Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients with Severe Preeclampsia: A Randomized, Single-Blind, Controlled Trial

2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Gilberto Arias-Hernández ◽  
Cruz Vargas-De-León ◽  
Claudia C Calzada-Mendoza ◽  
María Esther Ocharan-Hernández
Keyword(s):  
Blood Pressure ◽  
Intensive Care Unit ◽  
Heart Rate ◽  
Intensive Care ◽  
Outcome Measures ◽  
Repeated Measures ◽  
Severe Preeclampsia ◽  
Secondary Outcome ◽  
Control Group ◽  
Single Blind

Background. Postpartum preeclampsia is a serious disease related to high blood pressure that occurs commonly within the first six days after delivery. Objective. To evaluate if diltiazem improves blood pressure parameters in early puerperium patients with severe preeclampsia. Methodology. A randomized, single-blind longitudinal clinical trial of 42 puerperal patients with severe preeclampsia was carried out. Patients were randomized into two groups: the experimental group (n = 21) received diltiazem (60 mg) and the control group (n = 21) received nifedipine (10 mg). Both drugs were orally administered every 8 hours. Systolic, diastolic, and mean blood pressures as well as the heart rate were recorded and analyzed (two-way repeated measures ANOVA) at baseline and after 6, 12, 18, 24, 30, 36, 42, and 48 hours. Primary outcome measures were all the aforementioned blood pressure parameters. Secondary outcome measures included the number of hypertension and hypotension episodes along with the length of stay in the intensive care unit. Results. No statistical differences were found between groups (diltiazem vs. nifedipine) regarding basal blood pressure parameters. Interarm differences in blood pressure (systolic, diastolic, and mean) and heart rate were statistically significant between treatment groups from 6 to 48 hours. Patients in the diltiazem group had lower blood pressure levels than patients in the nifedipine group. Significantly, patients who received diltiazem had fewer hypertension and hypotension episodes and stayed fewer days in the intensive care unit than those treated with nifedipine. Conclusions. Diltiazem controlled arterial hypertension in a more effective and uniform manner in patients under study than nifedipine. Patients treated with diltiazem had fewer collateral effects and spent less time in the hospital. This trial is registered with NCT04222855.

Sign in / Sign up

Export Citation Format

Share Document